August 20

The Food and Drug Administration (FDA) has approved a new drug — Zalboraf — that has shown effectiveness in treating a challenging, and in some cases fatal, form of skin cancer.  This is the second melanoma treatment to be approved this year; in March, the FDA approved the drug Yervoy.  For more information, review the article at